Biotech · Private company
Formosa Pharmaceuticals, Inc.
Track this companyFree. Adds Formosa Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- APP13007, 0.05%Phase 3 · Ocular Inflammation and PainClinicalTrials.gov · fetched Nov 12, 2026
- APP13007, 0.05%Phase 3 · Ocular Inflammation and Pain After Cataract SurgeryClinicalTrials.gov · fetched Nov 12, 2026
- APP13007, 0.1%Phase 2 · Ocular Inflammation and Pain After Cataract SurgeryClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-studyPHASE3 · COMPLETED · started Mar 16, 2021ClinicalTrials.gov NCT04810962 · fetched Nov 12, 2026
- Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract SurgeryPHASE3 · COMPLETED · started Jan 11, 2021ClinicalTrials.gov NCT04739709 · fetched Nov 12, 2026
- A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of APP13007 to Treat Inflammation and Pain After Cataract SurgeryPHASE2 · COMPLETED · started Aug 13, 2019ClinicalTrials.gov NCT04089735 · fetched Nov 12, 2026